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Abstract One of the zinc ligands in human carbonic anhydrase II, His %, has been replaced with glutamic acid by site-directed mutagenesis. The 
mutation leads to a less stable zinc binding site and to significant non-local perturbations of the protein structure. The crystals are composed of a 
mixture of holo- and apoenzyme, and the side chain of G~u!‘~ has two conformations. In the holoenzyme, Gh? coordinates to the metal ion and is 
hydrogen bonded to Gln9’. In the apo form, GluN is hydrogen bonded to Asn6’. The mutation has resulted in a 500-fold decrease of the catalyzed 
rate of CO, hydration (k,,,/K,,,). 
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1. Introduction 
The catalytically essential zinc ion in carbonic anhydrase is 
firmly coordinated to the imidazole rings of three conserved 
histidine residues, Hisg4, Hisg6 and Hisiig, which are located on 
two adjacent, antiparallel B-strands. These ligands have very 
low crystallographic temperature factors and they undergo 
minimal perturbations upon binding of substrates or inhibitors 
or upon mutations at various positions in the active site [l-3]. 
These observations indicate that the zinc center is a stable and 
rather rigid entity and that its integrity is a prerequisite for 
proper catalytic function. 
To test the effects of altering the metal center, we have used 
site-specific mutagenesis to replace one of the zinc ligands with 
a glutamate residue which is a common ligand in zinc-contain- 
ing enzymes. We selected His g4 because it has a considerably 
larger surface accessibility than Hisg6 and His”’ and, therefore, 
this position might accommodate changes without severe alter- 
ations of the protein structure. 
2. Materials and methods 
In vitro site-directed mutagenesis was performed with the Muta- 
Gene system (Bio-Rad), which is based on the method of Kunkel[4]. 
Mutagenesis was performed on the single-stranded form of the expres- 
sion plasmid pACA, which was constructed in the laboratory of Dr. 
C.A. Fierke, Duke University, NC [5]. His%+ Glu human carbonic 
anhydrase II was produced after transformation of the E. coli strain 
BL21/DE3 [6] with the mutant plasmid. The cell growth conditions 
described by Forsman et al. [7] were used except hat ZnSO, was added 
to a final concentration of 0.5 mM and that the cells were grown at 
room temperature. The mutant enzyme was purified by ion-exchange 
chromatography on S-Sepharose Fast Flow (Pharmacia), which was 
equilibrated with 20 mM MES-NaOH, pH 6.2. The enzyme was eluted 
by step-wise increases of the (NH&SO, concentration and subse- 
quently dialyzed against 50 mM Tris-sulfate at pH 8.5 for 4 days. 
Initial rates of CO2 hydration were measured in a Hi-Tech stopped- 
flow apparatus at pH 8.8 and 25°C by the changing pH-indicator 
method [8,9]. The buffer-indicator pair was TAPS-NaOH with meta- 
cresol purple monitored at 578 nm. ZnSO, was added to the buffer in 
a 1: 1 enzytne/Zn2+ ratio. The ionic strength was maintained at 0.1 M 
by the addition of Na,SO,. Proper folding of the mutant enzyme was 
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checked by recording circular dichroism spectra between 200 nm and 
320 nm in a Jasco-720 spectropolarimeter. A Shimazu RF-500 spec- 
trofluorimeter was used to investigate the binding of the fluorescent 
inhibitor dansylamide (5dimethylaminonaphthalene-l-sulfonamide). 
Crystals of the mutant enzyme were grown by the hanging drop 
method using 2.3 M (NH&SO, in 50 mM Tris-H$O,, pH 8.5, contain- 
ing methyl mercuric chloride in a 1:4 molar enzyme/CH,HgCl ratio to 
prevent formation of intermolecular disulfide bonds [lo]. X-ray inten- 
sity data were collected using a Siemens (Xentronics) multiwire area 
detector mounted on a Rigaku RUZOOHB rotating anode generator (Cu 
K, radiation, 0.3 x 0.3 focal spot, graphite monochromator). The de- 
tector was placed 8.0 cm from the crystal. The Siemens 3-axis goniostat 
with a fixedx = 45” was used with 26’ = 15”. The crystal was rotated 
180” about w with a step size of 0.30” and an exposure time of 150 s 
per frame. The total data were collected from three crystals during 
about 36 h. The reflection data were integrated, reduced, merged and 
scaled using the Xengen program suite [I I]. We measured 24283 inten- 
sities corresponding to 13924 independent reflections to 2.1 A resolu- 
tion (89% of the available reflections). R, was 7.5%. A table with 
statistics of data collection and refinement is available upon request. 
All calculations were done on a VAX workstation 3100. 21F,I--IF,I 
and lFOl-lF,l electron density maps were calculated with the CCP4 
program package [12] and inspected at several stages of the work on 
the ESV and Evans & Sutherland PS390 stations using the programs 
FRODO [13,14] and 0 [l5]. The least squares refinement [16] was 
carried out with the program PROFFT [l7] refining both atomic posi- 
tions and individual temperature factors. The starting model for the 
refinement was the refined structure of human carbonic anhydrase II 
at 1.54 A resolution [3] without the side chain of residue 94 and 11 of 
the active site water molecules. The side chain of Glu% was subse- 
quently built into the model based on the electron density maps. 
3. Results 
After extensive dialysis against water the Hisg4+G1u mutant 
contained 0.37 mol of zinc per mol of enzyme indicating a 
rather weak binding of the metal ion. In the presence of one 
added equivalent of Zn” (17 PM) we obained the following 
steady-state kinetic parameters for the catalyzed CO, hydration 
in 50 mM TAPS-sulfate buffer at pH 8.8 and 25°C: k,, = 500 
SC’, K,,, = 2.2 mM, k,,lK, = 2.3 x lo5 M-' . s-‘. The correspond- 
ing values for the unmodified enzyme are k,,, = 1 x lo6 s-l, 
Km = lOmM, k,,,/K, = 1 x lO*M-‘.s-’ [18]. When ~,DM ofthe 
mutant enzyme was added to 10 ,uM of the fluorescent inhibi- 
tor, dansylamide, at pH 7.5, no change of the emission spec- 
trum attributable to the formation of an enzyme-dansylamide 
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complex could be observed. Addition of 50 mM Zn*’ did not 
alter the spectra. These results indicate K,, > 200 PM for the 
dansylamide complex of the mutant enzyme, while the wild- 
type enzyme has a Kd value of about 1 ,uM under similar 
conditions. 
The crystal structure was refined at 2.1 A resolution to a final 
R value of 15.2%. Significant deviations from the structure of 
wild-type enzyme were observed. Thus, the root-mean square 
deviation was 0.27 A for Ca atoms, 0.42 A for all atoms and 
0.53 A for side chain atoms. The Ca atom of residue 94 has 
moved 0.7 A compared to its position in wild-type enzyme. The 
zinc ion was refined to half occupancy with a B factor of 24.8 
A*. It shows a well-defined electron density in the 2]F,]-IF,] map 
after refinement. Apparently, the crystals contain approxi- 
mately equal proportions of holoenzyme and zinc-free apoen- 
zyme. A high B factor of 23.0 A* resulted for the zinc-bound 
water molecule (half occupancy, 2.5 A from the zinc ion) with- 
out bond restraints between it and the zinc ion during refine- 
ment. A quite small electron density (contour level of 0.7 a) for 
the zinc water was seen in the 2]F,]-IF,] map, and this probably 
reflects a very high mobility. 
Two different orientations of the side chain of residue 94 
were observed (Fig. 1). Each orientation had half occupancy 
and the B factors were 11 and 15 A2, respectively. In one 
orientation G~u~~ is coordinated to the zinc ion. In the other 
orientation, presumably representing the apoenzyme, two sol- 
vent molecules, Wat292 and Wat369, are displaced by the car- 
boxy1 oxygens of Glu 94 In the wild-type structure, both of these . 
water molecules are located within 4 8, of the side chain of His94 
and participate in the hydrogen-bonded network connecting 
the zinc-bound water molecule and His64, which functions as 
a proton shuttle group during catalysis [I]. The zinc ion has 
moved 0.6 A from its position in the wild-type enzyme. The zinc 
water (Wat263) and the ‘deep’ water (Wat338) have moved 0.8 A 
and 0.7 A, respectively (Fig. 1). The hydrogen-bond system 
involving the zinc-bound water molecule, Oyl of Thr’99 and 
O&l of G1u’06 is maintained [l-3]. while the tetrahedral coordi- 
nation geometry of the zinc ion is essentially maintained, the 
mutation has resulted in some changes of bond angles and 
zinc-ligand distances as shown in Table 1. 
Although the overall structure of the protein remains very 
similar to that of wild-type enzyme, significant non-local per- 
turbations of the structure were observed (Figs. 1 and 2). The 
Co’s of residues 125 through 136, forming an a helix and a turn 
region on the surface of the protein, have moved between 0.3 
and 0.9 A. In addition, the p-strands neighboring the zinc ion 
show a coordinated positional adjustment in response to the 
changes in metal coordination. For example, the side chains of 
Table 1 
Geometry of zinc coordination in Hi? + Glu human carbonic anhy- 
drase II 
Atom Distance (A) Angle (“) 
X X-Zn X-Zn-94 X-Zn-96 X-Zn-119 
0 263 2.5 (2.1) 99.7 (111.1) 112.3 (113.6) 114.3 (112.9) 
0~1 (N&2) 2.3 (2.1) 110.0 (103.9) 129.5 (115.3) 
94 
N&2 96 2.4 (2.1) 90.9 (99.2) 
N61 119 2.3 (2.1) 
Values in parentheses refer to wild-type enzyme [3]. 0 263 represents 







Fig. 1. Schematic diagram of part of the active site of human 
Hi?+Glu carbonic anhydrase II. Both GluW and His@ are 
shown in two orientations. Circles indicate positions of water mole- 
cules. Positions of Asn6’, Glt?” and Hi? in wild-type enzyme are drawn 
with thin lines. 
AsrP, GAUGE and Gln9* have undergone drastic rotations. The 
B factors of the side chain atoms of Gln9* are twice as high as 
for wild-type enzyme (23.4 and 11.7 A2, respectively). The N&2 
atom of Gln9* is hydrogen bonded to 0~2 of the metal-bound 
orientation of GAUGE and a water molecule. The 0~1 atom of 
Gln92, hydrogen bonded to N61 of His94 in wild-type enzyme, 
is linked to a water molecule in the mutant. In wild-type en- 
zyme, Asn6’ is within 4 A of both His94 and Gln9* and linked 
to Asn6* via a water molecule. In the mutant structure, Asn6’ 
is hydrogen-bonded irectly to Asn6* as well as to the non- 
coordinated orientation of GAUGE. Two conformations with 
nearly equal occupancy (6 : 4) were observed for the side chain 
of His64 (Fig. 1). 
4. Discussion 
Three major observations have emerged from this study. 
First, the replacement of the strictly conserved zinc ligand, 
His94, with Glu results in minor structural adjustments and the 
overall fold of the protein is intact. Second, the zinc ion inter- 
acts with GAUGE, but the affinity appears to be greatly reduced. 
Third, the modified enzyme has a residual catalytic activity. 
Unmodified human carbonic anhydrase II binds zinc with a 
very high affinity. Lindskog and Nyman [ 191 estimated an affin- 
ity constant, K,, of 1 x lo’* M-’ at pH 7 and Kiefer et al. [20] 
recently determined a value of 2.5 x 10” M-’ at the same pH. 
While we have not estimated the affinity constant for zinc 
binding to the mutant with GAUGE, such data have been pub- 
lished for mutants with Asp94 (K, = 7 x 10’ M-‘, pH 7) and 
CYSTS (K, = 3 x 10’ M-‘, pH 7) [21,22]. The structure of the 
His94+Glu mutant offers some explanations of the 
reduced zinc affinity. In wild-type enzyme, the three histidine 
ligands are rigidly posed to coordinate zinc in a suitable geom- 
etry. The positions of these ligands, as well as their hydrogen- 
bond contacts with other protein groups, are essentially un- 
changed in the apoenzyme, and a water molecule occupies the 
position left by the zinc ion [3]. Thus, the zinc ion can bind with 
a minimal structural change, which is an entropic advantage. 
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Fig. 2. Stereo diagram of part of the active site of human Hi?+Glu carbonic anhydrase II. The zinc ion and the zinc-bound water molecule are 
represented by crosses. Thin lines and crosses represent wild-type enzyme. Dotted lines represent hydrogen bonds. All hydrogen bonds are not shown. 
In the GAUGE mutant, our data suggest that this ligand changes 
its position as the zinc ion is removed, breaks its hydrogen bond 
with Gln9* and establishes a new hydrogen bond with Asn6’ 
(Fig. 1). In addition, the adjustment of the structure to accom- 
modate GAUGE as a zinc ligand has resulted in significant in- 
creases of all zinc- ligand bond lengths from 2.1 8, in the wild- 
type enzyme to 2.3-2.5 A in the mutant (Table 1). 
The interaction of carboxylate groups with metal ions in 
protein structures has been surveyed by Chakrabarti [23]. Both 
bidentate and monodentate binding of carboxylate groups have 
been observed and both syn and anti geometries relative to the 
carboxylate group have been found. Carboxylate-zinc interac- 
tions normally show distinct syn geometry [24]. The geometry 
of the Glu94-zinc interaction in our mutant is rather different 
from what has been found in zinc protein structures currently 
available in the Brookhaven Protein data Bank. The binding 
is monodentate with the projection of the Zn-O&l bond on the 
carboxylate plane being close along the O&l-C6 direction (5.4’) 
and with a deviation of 62” from the carboxylate plane. In this 
His94+ Asp mutant, a monodentate carboxylate coordination 
is also observed, but the interaction is close to the plane of the 
carboxylate group in a syn geometry [21]. 
Carbonic anhydrase is the only known zinc protein in which 
all three protein ligands are from tightly lined /I strands. When 
protein carboxylate groups are involved in metal binding, they 
usually come from helices, turns or regions with no regular 
secondary structure [23], all of which normally form more flex- 
ible binding sites than /I structures. While the rigidity of the 
/I-structure scaffold presumably contributes to the strong bind- 
ing of zinc to wild-type enzyme, it might prevent any alternative 
protein ligand from forming optimal interactions with the metal 
ion. 
The substitution of GAUGE for His94 results in a decrease of the 
maximal rate of catalyzed CO, hydration by a factor of 2000. 
Wild-type carbonic anhydrase II has an exceptionally high 
turnover rate, which has been partly attributed to a high nucle- 
ophilicity of a hydroxide ion bound to zinc in a complex of low 
coordination number with otherwise neutral ligands [25]. In- 
creased bond lengths and the introduction of a negatively 
charged carboxylate group in the coordination sphere are fac- 
tors that might lead to a decreased reactivity of a coordinated 
OH- in the mutant. In addition, GAUGE probably interferes with 
the formation of the appropriate transition state of the CO,- 
HCO; interconversion step. It has been proposed that the struc- 
ture of this transition state is similar to that of the HCO; 
complex with Thr*OO+His carbonic anhydrase II [l]. In this 
mutant, the protonated oxygen of the HCO; ion replaces the 
zinc-bound OH- ion, while a negatively charged oxygen atom 
is located 3.1 A from Csl of His94 [26]. Superimposing this 
HCO; orientation on the structure of the GAUGE mutant, we find 
that the distance between this negatively charged HCO; oxygen 
and a carboxylate oxygen of GAUGE is only 2.9 A. 
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